Intervention not reported
Outcomes relevant to participants' well‐being · people with TSC
1 finding from 1 review
Intervention not reported
Adverse events · people with TSC
The intervention probably leads to higher adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Response to skin lesionsb · people with TSC
The intervention leads to higher response to skin lesionsb (high certainty).
1 finding from 1 review
Intervention not reported
Frequency of seizure · people with TSC
The intervention probably leads to higher frequency of seizure (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of participants with an increased creatinine level · people with TSC
The intervention probably leads to lower number of participants with an increased creatinine level (moderate certainty).
1 finding from 1 review
Intervention not reported
FEV1/FVC ratio · people with TSC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Outcomes relevant to participants' well‐being · people with TSC
1 finding from 1 review
Intervention not reported
Adverse events · people with TSC
The intervention leads to higher adverse events (high certainty).
1 finding from 1 review
Intervention not reported
50% reduction in tumour size · people with TSC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Response to skin lesion · people with TSC
The intervention leads to higher response to skin lesion (high certainty).
1 finding from 1 review
Cardiac T2* value · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
MIC · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
LVEF (echocardiography) · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Ferritin (µg/L) · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Liver T2* value · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
LIC · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Adverse events · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Quality of life: CFQ‐R respiratory domain: absolute change from baseline · adults and children with CF with at least one class I mutation (PTC)
1 finding from 1 review
FEV1 % predicted: relative change from baseline · adults and children with CF with at least one class I mutation (PTC)
1 finding from 1 review
Adverse events relating to treatment Scale: mild, moderate, severe and total · adults and children with CF with at least one class I mutation (PTC)
1 finding from 1 review